KalVista Investigative Site

Milan 20097

0 studies enrolling now · 3 studies all time

What they study most

Angioedema, Hereditary, Types I and II, Hereditary Angioedema

Studies at this site

• Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II — Completed
• A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II — Stopped early
• A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II — Completed